Enablement Ruling Extinguishes Broad Antibody Claims, What C

Last week, a federal court in Delaware unsealed an opinion supporting its grant of summary judgment that U.S. Patent No. 7,033,590 (“the ’590 Patent”) is invalid for lack of enablement....

Related Keywords

Delaware , United States , Timothy Dyk , Genentech Hemlibra , Idenix Pharms , Ltd Takeda , Amgen , Genentech , Genentech Inc , Enzo Life Scis Inc , Supreme Court , Wyeth Cordis Corp , Takeda Pharmaceutical Co , Amgen Inc , Roche Molecular Sys Inc , Abbott Labs , Baxalta Inc , Takeda Pharmaceutical , Activating Antibodies , Circuit Judge Timothy Dyk , Federal Circuit , Enzo Life Scis , Molecular Sys , Judge Dyk ,